Stock Update: Merck & Co Inc (NYSE:MRK) – Merck, Bristol heat up immunotherapy race in lung cancer
January 12, 2015 at 15:34 PM EST
[Reuters – UK Focus] – Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding . . . → Read More: Stock Update: Merck & Co Inc (NYSE:MRK) – Merck, Bristol heat up immunotherapy race in lung cancer Similar Articles: Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – Merck, Bristol heat up immunotherapy race in lung cancer Market Update: Merck & Co Inc (NYSE:MRK) – Merck says animal food additive Zilmax seen safe in review Stock Update (NYSE:MRK): U.S. FDA approves Merck insomnia drug